Miguel Guia, Nilgun Alpay, António Gerardo, Yasmin Madney, Mohamed Abdelrahim, Haitham Saeed, Hadeer Harb, Gil Gonçalves, Bruno Cabrita, Jaber Alqahtani, Mohamad El-Khatib, Manuel Gómez-Ríos, Atefeh Fakharian, Laura Ciobanu, Habib Md Reazaul Karim, Edoardo Piervincenzi, Martin Scharffenberg, Paschalis Steiropoulos, William LeMaster, Igor Barjaktarevic, Jakob Wittenstein, Montserrat Diaz-Abad, Andreas Perren, Antonello Nicolini, Savino Spadaro, Giancarlo Garuti, Angelo Petroianni, Antonio Esquinas
High-flow nasal cannula oxygen therapy (HFNCOT) system consists of an air/oxygen supply system capable of delivering up to 100% humidified and heated oxygen at a flow rate of up to 80 L/min. The system includes a blender, active humidifier, single heated tube, and nasal cannula. HFNCOT has many physiological advantages compared with other standard oxygen therapies, such as anatomical dead space washout, more constant fraction of inspired oxygen, positive end-expiratory (PEEP) effect, supplement of adequate humidification and maintenance of muco-ciliary function...
November 2021: Turkish Thoracic Journal